I.V. Vitamin C
In May of 2006 I attended a conference in Dallas sponsored by the American College for Advancement in Medicine (of which I am a member). One of the speakers at the conference was Mark Levine M.D., presently with the National Institute of Health (NIH) Bethesda, Maryland. Dr. Levine’s passion is the use of high dose intravenous vitamin C against various types of cancer. Thus far, his work in laboratory has shown that lymphoma cancer cells, breast cancer cells and kidney cancer cells are totally susceptible (cell surviving rates ranging from 0% surviving cells to 0.3% surviving cells) to the killing effects of vitamin C, with doing absolutely no damage whatsoever to normal body cells. As an aside, this treatment was not effective against colon cancer cells lines. Since that time we have used intravenous vitamin C in all cancer settings, except colon. We have had a number of patients outlive their initial prognosis by incorporating this treatment as part of their overall treatment regimen.